Steven A. Shallcross

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Toronto
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Steven A. Shallcross
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steven A. Shallcross

Form 4 holding CEO and CFO, Director

Theriva Biologics, Inc.

Security class
Stock Options (right to buy)
Shares / value
475,000
Estimated value
Report date
05 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Elys Game Technology, Corp.

Security class
Stock Option (right to buy)
Shares / value
92,254
Estimated value
Report date
14 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Twin Vee PowerCats, Co.

Security class
Stock Options
Shares / value
5,500
Estimated value
Report date
23 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Steven A. Shallcross

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .